Cargando…
The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study
BACKGROUND: The association between metabolic dysfunction–associated fatty liver disease (MAFLD) and chronic kidney disease (CKD) is unclear. OBJECTIVE: This longitudinal cohort study aimed to test whether MAFLD plays an important role in the development of CKD. METHODS: This cohort study included 4...
Autores principales: | Wei, Suosu, Song, Jian, Xie, Yujie, Huang, Junzhang, Yang, Jianrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196898/ https://www.ncbi.nlm.nih.gov/pubmed/37140958 http://dx.doi.org/10.2196/45050 |
Ejemplares similares
-
The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
por: Wei, Suosu, et al.
Publicado: (2023) -
Sex Differences in the Impact of Metabolic Dysfunction-associated Fatty Liver Disease on the of Patients with Hepatocellular Carcinoma After Radical Resection
por: Huang, Junzhang, et al.
Publicado: (2023) -
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
por: Sun, Dan-Qin, et al.
Publicado: (2023) -
Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study
por: Hu, Qian, et al.
Publicado: (2022) -
Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC
por: Liu, Lei, et al.
Publicado: (2022)